SLU-PP-332 Protocol — Complete Dosing & Administration Guide

Dosing

How muchdo I take?

Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.

Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.

Standard Dose

500 mcg - 1 mg

Frequency

Once daily

Duration

8-12 weeks (research use)

No human trials exist; preclinical mice showed ERR-agonist exercise-mimetic and metabolic effects [1][2]. Dose shown is the range used in the research/biohacking community, not a validated human dose.

Timing

Best time to take

Morning dosing aligns with your body's natural metabolic rhythm. If taking before exercise, dose 30-60 minutes prior for optimal effect. Can also split doses between morning and early afternoon.

With food?

Can be taken with or without food. Some users prefer taking with a light meal to minimize any potential gastrointestinal discomfort.

If stacking

If combining with other metabolic compounds, space them out and start each one separately to identify individual effects. Some users stack with L-Carnitine for enhanced fat oxidation support.

Adjusting Your Dose

Increase if

+You've used the starting dose for 2+ weeks with no issues

+You're not noticing expected metabolic improvements

+Your body weight and composition goals aren't progressing

Decrease if

-You experience persistent GI discomfort

-Energy levels become erratic or you feel overstimulated

-Any unexpected side effects arise

-Sleep quality deteriorates

Signs of right dose

✓Improved exercise endurance and recovery

✓Gradual fat loss with maintained muscle

✓Stable energy throughout the day

✓Better overall metabolic markers if tested

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do Iuse it?

Reconstitution

What you need

•Bacteriostatic water (if using injectable form)

•Insulin syringes (29-31 gauge) for injection

•Alcohol swabs for cleaning

•Oral tablets/capsules don't require reconstitution

Example

For injectable form: If you have a 10mg vial and add 2mL of bacteriostatic water, you get 5mg/mL concentration. Each 0.1mL (10 units) equals 500mcg of SLU-PP-332.

For a 500mcg dose at 5mg/mL: draw 0.1mL (10 units on a standard insulin syringe). For 1000mcg: draw 0.2mL (20 units).

Injection

Route

Subcutaneous injection (just under the skin) or oral administration—oral is the preferred and more researched route

Best sites

•Belly fat area (2 inches from navel)

•Front or outer thigh

•Back of upper arm

Technique

1.Wash hands thoroughly with soap and water

2.Clean injection site with alcohol swab, let air dry

3.Pinch about an inch of skin

4.Insert needle at 45-90 degree angle

5.Push plunger slowly and steadily

6.Wait 5 seconds, then remove needle and apply light pressure

Storage

Before reconstitution

Store powder or tablets at room temperature (59-77°F / 15-25°C) in a cool, dry place away from direct sunlight. Refrigeration extends shelf life. Keep in original sealed container with desiccant if provided.

After reconstitution

If using injectable form, refrigerate at 36-46°F (2-8°C). Never freeze. Keep away from light. Oral forms should remain at room temperature in original packaging.

Signs of degradation

Discoloration or yellowing of powder/solution

Cloudy appearance (solution should be clear)

Unusual odor

Clumping or crystallization of powder

Sample Daily Schedule

Morning (6-9 AM)

250-500 mcg injection

Site: Oral or subcutaneous (belly area)

Morning dosing aligns with natural cortisol rhythm and metabolic activation. If exercising, take 30-60 minutes before for potential synergistic effects.

Early afternoon (12-2 PM, if splitting dose)

Site: Oral or rotate injection site

Second dose can help maintain consistent blood levels. Avoid dosing late in the day to prevent any potential impact on sleep.

Safety

Is itsafe?

Safety Profile

SLU-PP-332 has demonstrated a favorable safety profile in extensive preclinical studies. Mouse studies showed no severe adverse events even at relatively high doses, with researchers noting improvements in metabolic markers without negative effects on appetite, behavior, or organ function. The compound appears well-tolerated in animal models, though human clinical trials are still needed to fully establish its safety profile in people.

Most safety data comes from mouse studies conducted by Thomas Burris and colleagues at Saint Louis University and later the University of Florida. While preclinical results are encouraging, large-scale human clinical trials have not yet been completed. Always work with a healthcare provider when considering research compounds.

Common Side Effects

Experienced by some users

Mild GI discomfort

Some users report mild stomach upset, especially when starting. This is typical of compounds that affect metabolic pathways and usually resolves quickly.

Management: Take with a light meal. Start with lower doses and increase gradually. Symptoms typically improve within the first week.

Increased energy

You might feel more energetic than usual as your mitochondria become more active. This is actually the compound working as intended.

Management: Channel the extra energy into physical activity if possible. Avoid dosing late in the day if it affects sleep.

Mild warmth or temperature increase

A slight increase in body temperature can occur as metabolic rate increases. Think of it like your internal furnace burning a bit hotter.

Management: Stay well-hydrated. This effect is usually mild and indicates the compound is activating metabolic pathways.

Less Common

•Changes in appetite

•Mild headache

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Any signs of allergic reaction—stop immediately

×Persistent GI issues that don't improve with dose adjustment

×Significant changes in heart rate or blood pressure

×Sleep problems that persist beyond the first week

×Any side effect that feels concerning or unusual

×Your research protocol or cycle is complete

SLU-PP-332 is a research compound, not an FDA-approved medication. Never start, stop, or change your dosing without guidance from a qualified healthcare provider. This information is for educational purposes only—not medical advice.

Interactions

With other peptides

✓Can be combined safely. BPC-157 focuses on tissue healing while SLU-PP-332 targets metabolism—different mechanisms that may complement each other.

✓Safe to combine. TB-500 supports tissue repair and recovery, which may complement the metabolic enhancement from SLU-PP-332.

✓Can be used together. GHK-Cu works on cellular regeneration through different pathways.

!Use caution—both affect metabolism and glucose. Combining may lead to excessive metabolic effects. Consult a physician.

With medications

!Diabetes medications (metformin, insulin) - May compound glucose-lowering effects. Risk of hypoglycemia. Requires physician supervision and possible dose adjustment.

!Thyroid medications (levothyroxine) - Both affect metabolism. Combination may cause excessive metabolic stimulation. Consult endocrinologist.

✓Blood pressure medications - Metabolic changes may affect cardiovascular parameters. Monitor blood pressure closely.

✓Statins - Generally considered safe to combine. Both may actually complement each other for metabolic health.

With supplements

✓L-Carnitine - Potentially synergistic—both support fat oxidation. A popular combination in metabolic protocols.

✓CoQ10 - Safe and potentially complementary. Both support mitochondrial function through different mechanisms.

✓Caffeine/Stimulants - Use caution—combining may lead to excessive stimulation or cardiovascular stress.

✓Berberine - Both affect glucose metabolism. May be synergistic but monitor blood sugar if combining.

Want the Full Picture?

View the complete SLU-PP-332 research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.